glp-1 agonist weight loss mechanism and Maintenance Related to the of Action of Glucagon-Like Peptide 1 Receptor Agonists | Advances in Therapy Weight Reduction with GLP-1 Agonists

Everett, B

In addition, GLP-1RAs are valuable in the treatment and prevention of diseases of the nervous and cardiovascular system, endocrine disorders, or metabolic diseases due to their neuroprotective, cardiovascular protective, and metabolic regulatory effects

A prior study had shown that retatrutide and semaglutide reduced pancreatic tumor mass in mice, along with weight loss

However, tirzepatide is newer and individual responses vary

Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes

This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)